Chose your platform
Global CRO-Services Lab Services, Data Analysis & Integration
Chose your platform
Metabolic Phenotyping
We quantify metabolic pathway activity (Single Cells, Tissue, FFPE)
Lab Services
Integrated Proteomic, Transcriptomic, Metabolic Analysis
Data Services
Triple-Omics Data Integration for Actionable Insights
Sample Analysis
Cells, Organoids & Tissues, Including FFPE Samples
Innovation Alert
Introducing Single Cell Metabolic Phenotyping Services
Applications
QSM™ Biomarkers (Quantitative System Metabolism) are used in drug discovery and in pre-clinical and clinical studies across a range of disease areas including drug safety assessments.
Disease Area
​
Immuno-Oncology
Drug Safety
Metabolic Disorders
Longevity
Cardiology
Neurology
Study Phase
​
Preclinical Biomarkers
Safety / Pharmacology
Clinical Biomarkers
Clinical Biomarkers
Clinical Biomarkers
Bioenergy Marker Discovery
Download Case Study
Applications
About Doppelganger
QSM™ Metabolic Phenotyping is the first analytical platform to quantify metabolic pathway activity biomarkers from single cells and tissues, including FFPE. QSM™ (Quantitative System Metabolism) equips researchers with the tools to assess the activity of 22 distinct metabolic pathways, offering actionable insights.
Doppelganger Biosystem GmbH (Germany) supports scientists in preclinical, clinical, and translational research by providing crucial insights into the function and activity of central cellular metabolic pathways.
​
Want to learn more about QSM™?
Contact
Doppelganger Biosystem GmbH
Rebenstrasse 22
26121 Oldenburg, Germany
​
Phone North America:
+1 617 500-8221
Phone Europe:
+49 441 30446185
© 2024 Doppelganger Biosystem GmbH.
All products and services are for research use only. Not for use in diagnostic procedures.